Surveillance of branch-duct IPMN: Methods and frequency

Walter G. Park, Suresh T Chari

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs) are common premalignant cystic lesions of the pancreas. Most are incidentally discovered. The prevalence of malignancy at the time of initial identification of BD-IPMNs is very low and they harbor little threat of imminent malignant transformation. Therefore, despite their premalignant nature, immediate surgical resection for all BD-IPMNs is not recommended as the morbidity and mortality of surgery far outweigh the likely benefit of cancer prevention. The possibility of missing an opportunity to surgically cure early cancer, however, is a challenge given our limited understanding of the natural history along with suboptimal diagnostic tools. Consensus criteria for surveillance of BD-IPMNs and indications for surgery have been proposed in 2006 (a.k.a. Sendai criteria) and recently revised in 2012 (a.k.a. Fukuoka criteria). While the evidence to support current recommendations is limited, the trend of available data continues to support deliberate observation for most BD-IPMNs without high-risk stigmata or worrisome features of malignancy. Newer diagnostic tools with better accuracy for diagnosing BD-IPMNs and their dysplasia status are needed to improve clinical management.

Original languageEnglish (US)
Title of host publicationIntraductal Papillary Mucinous Neoplasm of the Pancreas
PublisherSpringer Japan
Pages137-150
Number of pages14
Volume9784431544722
ISBN (Print)9784431544722, 4431544712, 9784431544715
DOIs
StatePublished - Nov 1 2013

Fingerprint

Neoplasms
Christianity
Natural History
Pancreas
Observation
Morbidity
Mortality

Keywords

  • Branch duct
  • Intraductal papillary mucinous neoplasm
  • Surveillance

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Park, W. G., & Chari, S. T. (2013). Surveillance of branch-duct IPMN: Methods and frequency. In Intraductal Papillary Mucinous Neoplasm of the Pancreas (Vol. 9784431544722, pp. 137-150). Springer Japan. https://doi.org/10.1007/978-4-431-54472-2_11

Surveillance of branch-duct IPMN : Methods and frequency. / Park, Walter G.; Chari, Suresh T.

Intraductal Papillary Mucinous Neoplasm of the Pancreas. Vol. 9784431544722 Springer Japan, 2013. p. 137-150.

Research output: Chapter in Book/Report/Conference proceedingChapter

Park, WG & Chari, ST 2013, Surveillance of branch-duct IPMN: Methods and frequency. in Intraductal Papillary Mucinous Neoplasm of the Pancreas. vol. 9784431544722, Springer Japan, pp. 137-150. https://doi.org/10.1007/978-4-431-54472-2_11
Park WG, Chari ST. Surveillance of branch-duct IPMN: Methods and frequency. In Intraductal Papillary Mucinous Neoplasm of the Pancreas. Vol. 9784431544722. Springer Japan. 2013. p. 137-150 https://doi.org/10.1007/978-4-431-54472-2_11
Park, Walter G. ; Chari, Suresh T. / Surveillance of branch-duct IPMN : Methods and frequency. Intraductal Papillary Mucinous Neoplasm of the Pancreas. Vol. 9784431544722 Springer Japan, 2013. pp. 137-150
@inbook{aa48af53bfb4407a8012eb208c29d1b8,
title = "Surveillance of branch-duct IPMN: Methods and frequency",
abstract = "Branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs) are common premalignant cystic lesions of the pancreas. Most are incidentally discovered. The prevalence of malignancy at the time of initial identification of BD-IPMNs is very low and they harbor little threat of imminent malignant transformation. Therefore, despite their premalignant nature, immediate surgical resection for all BD-IPMNs is not recommended as the morbidity and mortality of surgery far outweigh the likely benefit of cancer prevention. The possibility of missing an opportunity to surgically cure early cancer, however, is a challenge given our limited understanding of the natural history along with suboptimal diagnostic tools. Consensus criteria for surveillance of BD-IPMNs and indications for surgery have been proposed in 2006 (a.k.a. Sendai criteria) and recently revised in 2012 (a.k.a. Fukuoka criteria). While the evidence to support current recommendations is limited, the trend of available data continues to support deliberate observation for most BD-IPMNs without high-risk stigmata or worrisome features of malignancy. Newer diagnostic tools with better accuracy for diagnosing BD-IPMNs and their dysplasia status are needed to improve clinical management.",
keywords = "Branch duct, Intraductal papillary mucinous neoplasm, Surveillance",
author = "Park, {Walter G.} and Chari, {Suresh T}",
year = "2013",
month = "11",
day = "1",
doi = "10.1007/978-4-431-54472-2_11",
language = "English (US)",
isbn = "9784431544722",
volume = "9784431544722",
pages = "137--150",
booktitle = "Intraductal Papillary Mucinous Neoplasm of the Pancreas",
publisher = "Springer Japan",

}

TY - CHAP

T1 - Surveillance of branch-duct IPMN

T2 - Methods and frequency

AU - Park, Walter G.

AU - Chari, Suresh T

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs) are common premalignant cystic lesions of the pancreas. Most are incidentally discovered. The prevalence of malignancy at the time of initial identification of BD-IPMNs is very low and they harbor little threat of imminent malignant transformation. Therefore, despite their premalignant nature, immediate surgical resection for all BD-IPMNs is not recommended as the morbidity and mortality of surgery far outweigh the likely benefit of cancer prevention. The possibility of missing an opportunity to surgically cure early cancer, however, is a challenge given our limited understanding of the natural history along with suboptimal diagnostic tools. Consensus criteria for surveillance of BD-IPMNs and indications for surgery have been proposed in 2006 (a.k.a. Sendai criteria) and recently revised in 2012 (a.k.a. Fukuoka criteria). While the evidence to support current recommendations is limited, the trend of available data continues to support deliberate observation for most BD-IPMNs without high-risk stigmata or worrisome features of malignancy. Newer diagnostic tools with better accuracy for diagnosing BD-IPMNs and their dysplasia status are needed to improve clinical management.

AB - Branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs) are common premalignant cystic lesions of the pancreas. Most are incidentally discovered. The prevalence of malignancy at the time of initial identification of BD-IPMNs is very low and they harbor little threat of imminent malignant transformation. Therefore, despite their premalignant nature, immediate surgical resection for all BD-IPMNs is not recommended as the morbidity and mortality of surgery far outweigh the likely benefit of cancer prevention. The possibility of missing an opportunity to surgically cure early cancer, however, is a challenge given our limited understanding of the natural history along with suboptimal diagnostic tools. Consensus criteria for surveillance of BD-IPMNs and indications for surgery have been proposed in 2006 (a.k.a. Sendai criteria) and recently revised in 2012 (a.k.a. Fukuoka criteria). While the evidence to support current recommendations is limited, the trend of available data continues to support deliberate observation for most BD-IPMNs without high-risk stigmata or worrisome features of malignancy. Newer diagnostic tools with better accuracy for diagnosing BD-IPMNs and their dysplasia status are needed to improve clinical management.

KW - Branch duct

KW - Intraductal papillary mucinous neoplasm

KW - Surveillance

UR - http://www.scopus.com/inward/record.url?scp=84930899409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930899409&partnerID=8YFLogxK

U2 - 10.1007/978-4-431-54472-2_11

DO - 10.1007/978-4-431-54472-2_11

M3 - Chapter

AN - SCOPUS:84930899409

SN - 9784431544722

SN - 4431544712

SN - 9784431544715

VL - 9784431544722

SP - 137

EP - 150

BT - Intraductal Papillary Mucinous Neoplasm of the Pancreas

PB - Springer Japan

ER -